Concepedia
Statistics
Publications
16
Citations
983
H-Index
Active since
2009
Affiliations
GW Pharmaceuticals (United Kingdom)(Current)
Newcastle University
AstraZeneca (United Kingdom)
Signature Research (United States)
University of Sheffield
Joanne M. Munck is an author at GW Pharmaceuticals (United Kingdom) specializing in medicine, cell biology, and pharmacology.
Top concepts
MedicineCell BiologyPharmacologyNatural SciencesRadiation OncologyOncologyBiochemistryTumor BiologyCancer TherapyDrug Discovery
Publications per year
2009–2021
Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K
Joanne M. Munck, Michael A. Batey, Yan Zhao et al. · Molecular Cancer Therapeutics · 2012 · 128 citations · Full text
Dual Inhibitor, Tumor Biology, Dna Double-strand Breaks +15
The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer
Fang Fang, Joanne M. Munck, Jessica Tang et al. · Clinical Cancer Research · 2014 · 96 citations · Full text
Inhibition of HSP90 by AT13387 Delays the Emergence of Resistance to BRAF Inhibitors and Overcomes Resistance to Dual BRAF and MEK Inhibition in Melanoma Models
Tomoko Smyth, Kim H.T. Paraiso, Keisha Hearn et al. · Molecular Cancer Therapeutics · 2014 · 91 citations · Full text
DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival
Liam Cornell, Joanne M. Munck, Clara Alsinet et al. · Clinical Cancer Research · 2014 · 85 citations · Full text
ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth
George A. Ward, Edward J. Lewis, Jong Sook Ahn et al. · Molecular Cancer Therapeutics · 2018 · 72 citations
1–5 of 16